Silence Therapeutics To Present At 12th Annual BIO CEO Investor Conference
LONDON and PALO ALTO, California, February 5 /PRNewswire/ -- Silence Therapeutics plc (AIM: SLN) today announced that Philip Haworth, Ph.D., chief executive officer, will deliver a corporate overview…